SCHEMBL27166361

SCHEMBL27166361

Cc1cc(S(=O)(=O)Cl)ccc1Nc1ncc(Br)c(Nc2cccc(F)c2C(N)=O)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 1/20 0.52
CDK5R1 Q15078 1/20 0.52
ZAP70 P43403 5/20 0.46
MAPK3 P27361 1/20 0.41
SYK P43405 2/20 0.41
ALK Q9UM73 2/20 0.41
CDK2 P24941 2/20 0.41
CDC7 O00311 1/20 0.41
DAPK3 O43293 1/20 0.41
JAK2 O60674 1/20 0.41
ROCK2 O75116 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
PAK4 O96013 1/20 0.41
PIM1 P11309 1/20 0.41
PRKACA P17612 1/20 0.41
CSNK1A1 P48729 1/20 0.41
CDK8 P49336 1/20 0.41
CLK2 P49760 1/20 0.41
GSK3A P49840 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25123673 0.93 CDK5 (0.53) CDK5CDK5R1ZAP70MAPK3SYK
SCHEMBL29991260 0.93 CDK5 (0.53) CDK5CDK5R1ZAP70MAPK3SYK
SCHEMBL25123656 0.91 CDK5 (0.55) CDK5CDK5R1ZAP70SYKALK
SCHEMBL22520990 0.87 CDK5 (0.47) CDK5CDK5R1ZAP70MAPK3SYK
SCHEMBL22521162 0.86 CDK5 (0.55) CDK5CDK5R1ZAP70SYKIGF1R
SCHEMBL31105062 0.85 CDK5 (0.52) CDK5CDK5R1ZAP70SYKALK
SCHEMBL29172717 0.85 ZAP70 (0.49) CDK5CDK5R1ZAP70SYKALK
SCHEMBL29172732 0.84 CDK5 (0.46) CDK5CDK5R1ZAP70MAPK3SYK
SCHEMBL25122528 0.84 CDK5 (0.46) CDK5CDK5R1ZAP70MAPK3SYK
SCHEMBL30872653 0.83 ZAP70 (0.45) CDK5CDK5R1ZAP70SYKALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117715904-A CDK2 degrading agents and uses thereof 凯麦拉医疗公司 2024-03-15 CN disclosed
EP-4334307-A1 CDK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-03-13 EP disclosed
WO-2022236058-A1 CDK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed